ALKS

Alkermes plc

Stock NASDAQ – Stock Market Prices, News & Analysis

Alkermes is a biopharmaceutical company focused on developing therapeutic innovations for chronic diseases, particularly in the fields of psychiatry and oncology.

$ 33.51
1.19 %

Alkermes plc

$ 33.51
1.19 %
ALKS

Alkermes is a biopharmaceutical company focused on developing therapeutic innovations for chronic diseases, particularly in the fields of psychiatry and oncology.

Price history of Alkermes plc
Price history of Alkermes plc

Performance & Momentum

6 Months 12.43 %
1 Year 21.09 %
3 Years 14.82 %
5 Years 52.23 %

Strategic Analysis

Alkermes plc • 2026

Alkermes plc is a biopharmaceutical company specializing in the development and commercialization of treatments for chronic conditions, with a strong presence in psychiatry and oncology. Its positioning is built on a niche approach in complex therapeutic areas, where value is created through clinical innovation, regulatory protection, and medical specialization.

Strengths
  • Focused positioning in highly complex chronic diseases, supported by recognized biopharmaceutical expertise.
  • Exposure to differentiated therapeutic segments, notably psychiatry, which can offer higher barriers to entry.
  • Broadly favorable stock trend across several time horizons, reflecting renewed market interest in the company.
Weaknesses
  • Dependence on clinical and regulatory outcomes, with a valuation profile sensitive to pipeline announcements.
  • Potentially uneven visibility due to the nature of the biotechnology sector, where execution risk remains high.
Momentum

Momentum appears positive and resilient, with constructive stock performance over the latest observed periods. This suggests that the market is becoming more confident in the group’s strategic trajectory, while reminding investors that a biotech remains exposed to volatility linked to clinical progress, regulatory decisions, and the monetization of its portfolio.

Similar stocks to Alkermes plc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone